$5.75 Billion is the total value of Avoro Capital Advisors LLC's 46 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | HORIZON THERAPEUTICS PLC | $842,760,000 | +1.7% | 9,000,000 | 0.0% | 14.66% | +2.5% | |
| UTHR | UNITED THERAPEUTICS CORP | $538,230,000 | +7.3% | 3,000,000 | 0.0% | 9.36% | +8.0% | |
| XLRN | ACCELERON PHARMA INC | $376,470,000 | -7.5% | 3,000,000 | 0.0% | 6.55% | -6.8% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $138,809,000 | -16.7% | 1,425,000 | 0.0% | 2.42% | -16.1% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $137,676,000 | +10.5% | 1,650,000 | 0.0% | 2.40% | +11.3% | |
| MRSN | MERSANA THERAPEUTICS INC | $92,344,000 | -16.1% | 6,800,000 | 0.0% | 1.61% | -15.5% | |
| XENE | XENON PHARMACEUTICALS INC | $67,963,000 | +4.0% | 3,650,000 | 0.0% | 1.18% | +4.8% | |
| MARINUS PHARMACEUTICALS INC | $58,036,000 | +15.9% | 3,235,000 | 0.0% | 1.01% | +16.8% | ||
| TRILLIUM THERAPEUTICS INC | $55,290,000 | -9.7% | 5,700,000 | 0.0% | 0.96% | -9.0% | ||
| CBAY | CYMABAY THERAPEUTICS INC | $44,908,000 | -4.0% | 10,300,000 | 0.0% | 0.78% | -3.3% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $29,376,000 | -25.6% | 4,365,000 | 0.0% | 0.51% | -25.0% | |
| DSGN | DESIGN THERAPEUTICS INC | $26,410,000 | -33.5% | 1,468,318 | 0.0% | 0.46% | -33.1% | |
| AMRN | AMARIN CORP PLCsponsored adr | $26,280,000 | -29.5% | 6,000,000 | 0.0% | 0.46% | -28.9% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $24,538,000 | -0.2% | 876,986 | 0.0% | 0.43% | +0.5% | |
| RNA | AVIDITY BIOSCIENCES INC | $13,467,000 | +13.3% | 545,000 | 0.0% | 0.23% | +14.1% | |
| FENC | FENNEC PHARMACEUTICALS INC | $12,174,000 | +17.4% | 1,670,000 | 0.0% | 0.21% | +18.4% | |
| GNCA | GENOCEA BIOSCIENCES INC | $11,897,000 | -13.7% | 5,084,184 | 0.0% | 0.21% | -13.0% | |
| BCTG | BCTG ACQUISITION CORP | $9,096,000 | +2.2% | 800,000 | 0.0% | 0.16% | +2.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.